cover
Contact Name
Siska Musiam
Contact Email
siska@stikes-isfi.ac.id
Phone
+62511-3301610
Journal Mail Official
jiis@stikes-isfi.ac.id
Editorial Address
Jl. Flamboyan III/7c Kayu Tangi 70123 Banjarmasin Kalimantan Selatan
Location
Kota banjarmasin,
Kalimantan selatan
INDONESIA
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan
ISSN : 2502647X     EISSN : 25031902     DOI : https://doi.org/10.36387/jiis
Core Subject : Health,
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan is a broad-based primary journal covering all branches of pharmacy and its sub-disciplines that contains complete research articles, short communication and review articles. JIIS is a forum for the publication of quality and original works that open discussions in the field of pharmacy and health sciences.
Articles 476 Documents
Aktivitas Antidislipidemia Ekstrak Etanol Rimpang Temulawak (Curcuma xanthorrhiza) terhadap Kadar Low-Density Lipoprotein (LDL) dan High-Density Lipoprotein (HDL) pada Tikus Putih Jantan Galur Wistar Rizal Fauzi; Emelda; Nurul Jannah; Moch. Saiful Bachri; Nurul Kusumawardani; Daru Estiningsih; Sri Suprapti
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 11 No 2 (2026): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v11i2.3095

Abstract

Dyslipidemic is a lipid metabolism disorder characterized by an increase or decrease in plasma lipid fraction levels. Curcuma xanthorrhiza rhizome contains flavonoids, phenols, and curcumin, which act as antioxidants. The antioxidant activity of pure xanthorrhizol from Curcuma xanthorrhiza can reduce LDL peroxidation. The purpose of this study was to determine the antidyslipidemic activity of ethanol extract of Curcuma xanthorrhiza rhizome (EECR) on LDL and HDL levels in male wistar rats induced by a high-fat diet. Rats were fed a high-fat diet (HFD). Rats were divided into five groups, group 1 (negative control) dyslipidemia rats and given CMC-Na suspension, group 2 (positive control) dyslipidemia rats and given simvastatin suspension, group 4, 5 and 6 (treatment) dyslipidemia rats given EECR with doses of 400 mg/kg.b.w, 600 mg/kg.b.w and 800 mg/kg.b.w. Measurement of HDL and LDL levels was carried out before treatment (pretest) and after treatment (posttest). The results of statistical analysis between pretest and posttest data showed that there was a significant increase in HDL levels at doses of 600 mg/kg.b.w & 800mg/kg.b.w (sig 0.000; p <0.05) and a decrease in LDL levels at doses of 400 mg/kg.b.w, 600 mg/kg.b.w and 800 mg/kg.b.w (sig 0.000; p <0.05). The decrease in LDL levels at a dose of 800 mg/kg.b.w had an effect equivalent to simvastatin as a positive control (sig 0.057; p>0.05). The ethanol extract of Curcuma xanthorrhiza rhizome has antidyslipidemic activity in male wistar rats which is indicated by an increase in HDL levels and a decrease in LDL levels.
Potensi ekstrak daun Ipomoea pes-caprae dari Lombok Utara pada aktivitas antiplatelet pada strain tikus balb/C Ilsa Hunaifi; Raisya Hasina; Tuhfatul Ulya; Baiq Risky Wahyu Lisnasari; Afifah Tasya Kamila; Putri Syerin Salsabila; Noval Tunggal Arya Rezky; Muhammad Naufal Farras Ananta; Lina Permatasari; Hidayat Lalu Husnul
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 11 No 2 (2026): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v11i2.3096

Abstract

Antiplatelet agents are widely used for the secondary prevention of cerebrovascular disorders to reduce stroke risk, but their use is associated with adverse effects such as bleeding and drug resistance. Therefore, the development of novel antiplatelet agents, including those derived from natural products, is necessary. Ipomoea pes-caprae leaf extract has demonstrated stronger antiplatelet activity than the stem in vitro, with an inhibition concentration of 727.78 µg/mL. This study aimed to evaluate the antiplatelet aggregation effect of I. pes-caprae leaf extract by assessing bleeding and clotting time. An experimental study was conducted using Balb/C mice divided into a positive control group (aspirin 80 mg), a negative control group, and treatment groups receiving I. pes-caprae leaf extract at doses of 20, 40, 80, 100, and 120 mg/kg body weight. Bleeding and clotting times were measured before treatment (D0) and nine days after extract administration (D9). The results showed no statistically significant difference in bleeding time between the positive control and extract-treated groups at any dose. However, bleeding time was significantly increased in mice receiving extract doses of 40, 80, and 100 mg/kg body weight compared to the negative control (p < 0.05). A significant prolongation of clotting time was observed at a dose of 100 mg/kg body weight compared to the negative control (p < 0.05). In conclusion, I. pes-caprae leaf extract increases bleeding and clotting times, with the most pronounced effect at 100 mg/kg body weight, indicating its potential as a natural antiplatelet agent.
CORRELATION BETWEEN PATIENT CHARACTERISTICS AND MEDICATION ADHERENCE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS IN INDONESIAN PRIMARY HEALTHCARE Riza Alfian; Muhammad Hafizh Abiyyu Fathin Fawwazi; Wirawan Adikusuma; Sita Rizky Mardia; Leonov Rianto
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 11 No 2 (2026): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v11i2.3104

Abstract

Medication adherence is a key determinant of successful type 2 diabetes mellitus (T2DM) management, yet evidence regarding adherence levels and their correlation with patient characteristics in Indonesian primary healthcare remains limited. This study aimed to describe medication adherence levels and analyze the correlation between patient characteristics and medication adherence among patients with T2DM receiving care at primary healthcare centers in Indonesia. A prospective cross-sectional study was conducted among 199 patients with T2DM attending eight primary healthcare centers (Puskesmas) in Banjarmasin, Indonesia. Participants were recruited using consecutive sampling. Medication adherence was assessed using the 12-item Adherence to Refills and Medications Scale (ARMS), and adherence categories were determined using the median ARMS score. Correlation analyses were performed using Pearson's or Spearman's correlation tests according to variable characteristics. Of the 199 participants, 109 (54.8%) demonstrated higher medication adherence, while 90 (45.2%) were classified as having lower adherence. Analysis of individual ARMS items indicated that forgetting to take medications, delayed medication refills, and running out of medications before scheduled refills were the most common non-adherent behaviors. Correlation analysis showed that duration of diabetes was the only patient characteristic significantly correlated with medication adherence (r = −0.156, p = 0.028), indicating that a longer duration of diabetes was associated with better adherence. No significant correlations were observed for age, sex, educational level, occupation, or treatment regimen (p > 0.05). In conclusion, although most patients demonstrated higher medication adherence, nearly half remained poorly adherent. Duration of diabetes showed a weak but significant correlation with medication adherence
Potensi Antidiabetes dari Genus Hydrolea: Tinjauan Naratif Mengenai Bukti Terkini dan Wawasan Mekanistik Eka Kumalasari; Dwi Rizki Febrianti; Amaliyah Wahyuni; Laela Hayu Nurani; Akrom; Rakhmadhan Niah
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 11 No 2 (2026): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v11i2.3143

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia resulting from impaired insulin secretion, insulin action, or both, and is closely associated with oxidative stress and inflammation. The genus Hydrolea contains diverse secondary metabolites, and several species have been reported to exhibit activities potentially relevant to diabetes management. This narrative review summarizes the available evidence on the phytochemistry, antidiabetic activity, and potential mechanisms of Hydrolea. Literature searches were conducted in PubMed, Scopus, ScienceDirect, Google Scholar, and Garuda using “Hydrolea” as the sole search term. No publication-year restriction was applied to PubMed, Scopus, ScienceDirect, or Garuda, whereas Google Scholar was restricted to publications from 2000 to 2026. Studies were selected based on their relevance to antidiabetic activity and supporting phytochemical, antioxidant, and pharmacological evidence. The available evidence indicates that H. zeylanica is the most extensively investigated species, with reported antihyperglycemic effects, α-glucosidase and α-amylase inhibition, improved insulin sensitivity and glucose homeostasis, and modulation of oxidative stress and inflammation. In contrast, evidence for H. spinosa remains limited despite its ethnomedicinal use and preliminary pharmacological findings. Overall, Hydrolea represents a potential source of antidiabetic bioactive compounds; however, current evidence remains limited and is predominantly derived from H. zeylanica. Further bioassay-guided isolation, structural characterization, molecular target validation, and in vivo studies are required to identify active compounds and confirm their mechanisms of action.
UJI BIOAVAILABILITAS SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS (SNEDDS) ASIATICOSIDE EKSTRAK ETANOL DAUN PEGAGAN (Centella asiatica) PADA TIKUS PUTIH (Rattus norvegicus) Awfiyah Aghna Widyandhari; Gunawan Setiyadi
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 11 No 2 (2026): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v11i2.3148

Abstract

Asiaticoside is a bioactive compound from Centella asiatica with limited oral bioavailability due to its poor aqueous solubility. This study aimed to evaluate the effect of a self-nanoemulsifying drug delivery system (SNEDDS) on the pharmacokinetic profile and oral bioavailability from ethanolic extract of of C. asiaticoside compared with conventional C. asiatica ethanolic extract. An HPLC method was validated for asiaticoside determination in rat serum based on selectivity, linearity, sensitivity, accuracy, and precision. Wistar rats were administered asiaticoside from ethanolic extract or SNEDDS orally, and blood samples were collected at predetermined intervals up to 360 minutes. Pharmacokinetic parameters including Cmax, Tmax, AUC₀–t, and relative bioavailability were subsequently determined. The HPLC method showed good linearity over 0.39–6.25 µg/mL with an R² of 0.9995 and acceptable accuracy and precision. SNEDDS increased the Cmax from 0.02362 ± 0.00207 to 0.15374 ± 0.00956 µg/mL and reduced Tmax from 240 to 120 minutes. The AUC₀–t increased from 5.22352 ± 0.16074 to 20.8248 ± 0.52093 µg·min/mL, resulting in 398.68% relative bioavailability, approximately 3.99-fold higher than the extract. The novelty of this study lies in demonstrating the substantial enhancement of asiaticoside absorption through SNEDDS. These findings provide a basis for developing nanoemulsion-based delivery systems to improve the oral delivery of poorly water-soluble bioactive compounds.
POLA PENGGUNAAN ANTIDIABETES–ANTIHIPERTENSI DAN POTENSI INTERAKSI OBAT PADA PASIEN DIABETES MELITUS TIPE 2 DENGAN HIPERTENSI: STUDI RETROSPEKTIF DI RSUD SULTAN SURIANSYAH BANJARMASIN Muhammad Faqih; Nadia Aprilia; Fitrah Shafran Ilahi; Abdul Mahmud Yumassik; Nordin; Anshar Timur Samudra; Fitri Yuliani; Noor Aisyah
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 11 No 2 (2026): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v11i2.3217

Abstract

The concurrent treatment of type 2 diabetes mellitus (T2DM) and hypertension often involves multiple medicines, making potential drug–drug interactions an important safety consideration. To describe antidiabetic and antihypertensive prescribing patterns, identify potential drug interactions, and assess their associations with patient and treatment characteristics. This retrospective, cross-sectional descriptive–analytic study reviewed 180 inpatient medical records from Sultan Suriansyah Regional General Hospital, Banjarmasin, covering December 2024 to July 2025. Records were selected through purposive sampling. Descriptive statistics and chi-square or Fisher’s exact tests were applied as appropriate. Levemir FlexPen accounted for 95 of 294 documented antidiabetic uses (32.3%), while amlodipine accounted for 128 of 368 antihypertensive uses (34.8%). Potential drug interactions were identified in 129 of 180 records (71.7%). Among 231 potential interaction pairs, 220 (95.2%) were pharmacodynamic and 219 (94.8%) were classified as moderate. Medication count was significantly associated with potential interactions (p = 0.007; OR = 0.072; 95% CI = 0.008–0.632). Potential drug interactions were identified in most records. Among the assessed factors, the number of medications showed a statistically significant association with potential interactions.